nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisone—CYP2C19—Teniposide—lymphatic system cancer	0.124	0.198	CbGbCtD
Prednisone—SLCO1A2—Methotrexate—lymphatic system cancer	0.108	0.172	CbGbCtD
Prednisone—ABCB1—Mitoxantrone—lymphatic system cancer	0.0699	0.112	CbGbCtD
Prednisone—CYP3A4—Cytarabine—lymphatic system cancer	0.0608	0.0971	CbGbCtD
Prednisone—CYP3A4—Teniposide—lymphatic system cancer	0.0598	0.0957	CbGbCtD
Prednisone—ALB—Methotrexate—lymphatic system cancer	0.0556	0.089	CbGbCtD
Prednisone—ABCB1—Vincristine—lymphatic system cancer	0.0481	0.0769	CbGbCtD
Prednisone—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0419	0.0669	CbGbCtD
Prednisone—ABCB1—Methotrexate—lymphatic system cancer	0.0291	0.0465	CbGbCtD
Prednisone—CYP3A4—Vincristine—lymphatic system cancer	0.0288	0.0461	CbGbCtD
Prednisone—Weight decreased—Vincristine—lymphatic system cancer	0.00075	0.002	CcSEcCtD
Prednisone—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.000746	0.00199	CcSEcCtD
Prednisone—Erectile dysfunction—Mitoxantrone—lymphatic system cancer	0.000743	0.00199	CcSEcCtD
Prednisone—Flushing—Bleomycin—lymphatic system cancer	0.000739	0.00197	CcSEcCtD
Prednisone—Depression—Vincristine—lymphatic system cancer	0.000737	0.00197	CcSEcCtD
Prednisone—Anorexia—Fludarabine—lymphatic system cancer	0.000735	0.00196	CcSEcCtD
Prednisone—Weight increased—Mitoxantrone—lymphatic system cancer	0.000735	0.00196	CcSEcCtD
Prednisone—Weight decreased—Mitoxantrone—lymphatic system cancer	0.00073	0.00195	CcSEcCtD
Prednisone—Acute coronary syndrome—Vincristine—lymphatic system cancer	0.000729	0.00195	CcSEcCtD
Prednisone—Hyperglycaemia—Mitoxantrone—lymphatic system cancer	0.000728	0.00194	CcSEcCtD
Prednisone—Myocardial infarction—Vincristine—lymphatic system cancer	0.000724	0.00193	CcSEcCtD
Prednisone—Neuropathy peripheral—Vincristine—lymphatic system cancer	0.000724	0.00193	CcSEcCtD
Prednisone—Feeling abnormal—Teniposide—lymphatic system cancer	0.000723	0.00193	CcSEcCtD
Prednisone—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.000718	0.00192	CcSEcCtD
Prednisone—Acute coronary syndrome—Mitoxantrone—lymphatic system cancer	0.000709	0.00189	CcSEcCtD
Prednisone—Nausea—Mechlorethamine—lymphatic system cancer	0.000707	0.00189	CcSEcCtD
Prednisone—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.000705	0.00188	CcSEcCtD
Prednisone—Alopecia—Bleomycin—lymphatic system cancer	0.000704	0.00188	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.000703	0.00188	CcSEcCtD
Prednisone—Haemoglobin—Carmustine—lymphatic system cancer	0.000699	0.00187	CcSEcCtD
Prednisone—Urticaria—Teniposide—lymphatic system cancer	0.000697	0.00186	CcSEcCtD
Prednisone—Haemorrhage—Carmustine—lymphatic system cancer	0.000695	0.00186	CcSEcCtD
Prednisone—Abdominal pain—Teniposide—lymphatic system cancer	0.000694	0.00185	CcSEcCtD
Prednisone—Body temperature increased—Teniposide—lymphatic system cancer	0.000694	0.00185	CcSEcCtD
Prednisone—Erythema—Bleomycin—lymphatic system cancer	0.000693	0.00185	CcSEcCtD
Prednisone—Paraesthesia—Fludarabine—lymphatic system cancer	0.000693	0.00185	CcSEcCtD
Prednisone—Hallucination—Carmustine—lymphatic system cancer	0.000691	0.00185	CcSEcCtD
Prednisone—Connective tissue disorder—Carmustine—lymphatic system cancer	0.000683	0.00182	CcSEcCtD
Prednisone—Dyspepsia—Fludarabine—lymphatic system cancer	0.000679	0.00181	CcSEcCtD
Prednisone—Ulcer—Methotrexate—lymphatic system cancer	0.000678	0.00181	CcSEcCtD
Prednisone—Decreased appetite—Fludarabine—lymphatic system cancer	0.000671	0.00179	CcSEcCtD
Prednisone—Fatigue—Fludarabine—lymphatic system cancer	0.000665	0.00178	CcSEcCtD
Prednisone—Hallucination—Vincristine—lymphatic system cancer	0.00066	0.00176	CcSEcCtD
Prednisone—Constipation—Fludarabine—lymphatic system cancer	0.00066	0.00176	CcSEcCtD
Prednisone—Bradycardia—Mitoxantrone—lymphatic system cancer	0.000658	0.00176	CcSEcCtD
Prednisone—Vasculitis—Methotrexate—lymphatic system cancer	0.000657	0.00175	CcSEcCtD
Prednisone—Connective tissue disorder—Vincristine—lymphatic system cancer	0.000652	0.00174	CcSEcCtD
Prednisone—Eye disorder—Carmustine—lymphatic system cancer	0.000649	0.00173	CcSEcCtD
Prednisone—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.000649	0.00173	CcSEcCtD
Prednisone—Hypersensitivity—Teniposide—lymphatic system cancer	0.000647	0.00173	CcSEcCtD
Prednisone—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.000646	0.00173	CcSEcCtD
Prednisone—Flushing—Carmustine—lymphatic system cancer	0.000645	0.00172	CcSEcCtD
Prednisone—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.000643	0.00172	CcSEcCtD
Prednisone—Anaemia—Bleomycin—lymphatic system cancer	0.000641	0.00171	CcSEcCtD
Prednisone—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000636	0.0017	CcSEcCtD
Prednisone—Asthenia—Teniposide—lymphatic system cancer	0.00063	0.00168	CcSEcCtD
Prednisone—Malaise—Bleomycin—lymphatic system cancer	0.000625	0.00167	CcSEcCtD
Prednisone—Pruritus—Teniposide—lymphatic system cancer	0.000621	0.00166	CcSEcCtD
Prednisone—Arrhythmia—Carmustine—lymphatic system cancer	0.000621	0.00166	CcSEcCtD
Prednisone—Alopecia—Carmustine—lymphatic system cancer	0.000614	0.00164	CcSEcCtD
Prednisone—Skin exfoliation—Methotrexate—lymphatic system cancer	0.000612	0.00163	CcSEcCtD
Prednisone—Body temperature increased—Fludarabine—lymphatic system cancer	0.00061	0.00163	CcSEcCtD
Prednisone—Mental disorder—Carmustine—lymphatic system cancer	0.000609	0.00163	CcSEcCtD
Prednisone—Erythema—Carmustine—lymphatic system cancer	0.000605	0.00162	CcSEcCtD
Prednisone—Malnutrition—Carmustine—lymphatic system cancer	0.000605	0.00162	CcSEcCtD
Prednisone—Angiopathy—Vincristine—lymphatic system cancer	0.000602	0.00161	CcSEcCtD
Prednisone—Diarrhoea—Teniposide—lymphatic system cancer	0.000601	0.0016	CcSEcCtD
Prednisone—Myalgia—Bleomycin—lymphatic system cancer	0.00059	0.00158	CcSEcCtD
Prednisone—Alopecia—Vincristine—lymphatic system cancer	0.000586	0.00157	CcSEcCtD
Prednisone—Discomfort—Bleomycin—lymphatic system cancer	0.000583	0.00156	CcSEcCtD
Prednisone—Mental disorder—Vincristine—lymphatic system cancer	0.000581	0.00155	CcSEcCtD
Prednisone—Ecchymosis—Methotrexate—lymphatic system cancer	0.00058	0.00155	CcSEcCtD
Prednisone—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.000577	0.00154	CcSEcCtD
Prednisone—Alopecia—Mitoxantrone—lymphatic system cancer	0.000571	0.00152	CcSEcCtD
Prednisone—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.000571	0.00152	CcSEcCtD
Prednisone—Vision blurred—Carmustine—lymphatic system cancer	0.00057	0.00152	CcSEcCtD
Prednisone—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000568	0.00152	CcSEcCtD
Prednisone—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000566	0.00151	CcSEcCtD
Prednisone—Oedema—Bleomycin—lymphatic system cancer	0.000566	0.00151	CcSEcCtD
Prednisone—Erythema—Mitoxantrone—lymphatic system cancer	0.000562	0.0015	CcSEcCtD
Prednisone—Infection—Bleomycin—lymphatic system cancer	0.000562	0.0015	CcSEcCtD
Prednisone—Anaemia—Carmustine—lymphatic system cancer	0.000559	0.00149	CcSEcCtD
Prednisone—Vomiting—Teniposide—lymphatic system cancer	0.000558	0.00149	CcSEcCtD
Prednisone—Sepsis—Methotrexate—lymphatic system cancer	0.000556	0.00149	CcSEcCtD
Prednisone—Agitation—Carmustine—lymphatic system cancer	0.000556	0.00148	CcSEcCtD
Prednisone—Asthenia—Fludarabine—lymphatic system cancer	0.000554	0.00148	CcSEcCtD
Prednisone—Rash—Teniposide—lymphatic system cancer	0.000553	0.00148	CcSEcCtD
Prednisone—Dermatitis—Teniposide—lymphatic system cancer	0.000553	0.00148	CcSEcCtD
Prednisone—Headache—Teniposide—lymphatic system cancer	0.00055	0.00147	CcSEcCtD
Prednisone—Pruritus—Fludarabine—lymphatic system cancer	0.000546	0.00146	CcSEcCtD
Prednisone—Anorexia—Bleomycin—lymphatic system cancer	0.000539	0.00144	CcSEcCtD
Prednisone—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.000538	0.00144	CcSEcCtD
Prednisone—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.000535	0.00143	CcSEcCtD
Prednisone—Anaemia—Vincristine—lymphatic system cancer	0.000534	0.00143	CcSEcCtD
Prednisone—Agitation—Vincristine—lymphatic system cancer	0.000531	0.00142	CcSEcCtD
Prednisone—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00053	0.00142	CcSEcCtD
Prednisone—Diarrhoea—Fludarabine—lymphatic system cancer	0.000528	0.00141	CcSEcCtD
Prednisone—Convulsion—Carmustine—lymphatic system cancer	0.000524	0.0014	CcSEcCtD
Prednisone—Hypertension—Carmustine—lymphatic system cancer	0.000522	0.00139	CcSEcCtD
Prednisone—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000522	0.00139	CcSEcCtD
Prednisone—Nausea—Teniposide—lymphatic system cancer	0.000521	0.00139	CcSEcCtD
Prednisone—Anaemia—Mitoxantrone—lymphatic system cancer	0.00052	0.00139	CcSEcCtD
Prednisone—Vertigo—Vincristine—lymphatic system cancer	0.000519	0.00139	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000515	0.00138	CcSEcCtD
Prednisone—Myalgia—Carmustine—lymphatic system cancer	0.000515	0.00138	CcSEcCtD
Prednisone—Anxiety—Carmustine—lymphatic system cancer	0.000513	0.00137	CcSEcCtD
Prednisone—Paraesthesia—Bleomycin—lymphatic system cancer	0.000508	0.00136	CcSEcCtD
Prednisone—Malaise—Mitoxantrone—lymphatic system cancer	0.000507	0.00135	CcSEcCtD
Prednisone—Convulsion—Vincristine—lymphatic system cancer	0.0005	0.00134	CcSEcCtD
Prednisone—Hypertension—Vincristine—lymphatic system cancer	0.000499	0.00133	CcSEcCtD
Prednisone—Oedema—Carmustine—lymphatic system cancer	0.000494	0.00132	CcSEcCtD
Prednisone—Decreased appetite—Bleomycin—lymphatic system cancer	0.000492	0.00131	CcSEcCtD
Prednisone—Myalgia—Vincristine—lymphatic system cancer	0.000492	0.00131	CcSEcCtD
Prednisone—Infection—Carmustine—lymphatic system cancer	0.000491	0.00131	CcSEcCtD
Prednisone—Vomiting—Fludarabine—lymphatic system cancer	0.000491	0.00131	CcSEcCtD
Prednisone—Convulsion—Mitoxantrone—lymphatic system cancer	0.000487	0.0013	CcSEcCtD
Prednisone—Rash—Fludarabine—lymphatic system cancer	0.000486	0.0013	CcSEcCtD
Prednisone—Dermatitis—Fludarabine—lymphatic system cancer	0.000486	0.0013	CcSEcCtD
Prednisone—Hypertension—Mitoxantrone—lymphatic system cancer	0.000486	0.0013	CcSEcCtD
Prednisone—Headache—Fludarabine—lymphatic system cancer	0.000483	0.00129	CcSEcCtD
Prednisone—Tachycardia—Carmustine—lymphatic system cancer	0.000482	0.00129	CcSEcCtD
Prednisone—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000479	0.00128	CcSEcCtD
Prednisone—Myalgia—Mitoxantrone—lymphatic system cancer	0.000479	0.00128	CcSEcCtD
Prednisone—Anxiety—Mitoxantrone—lymphatic system cancer	0.000477	0.00127	CcSEcCtD
Prednisone—Lethargy—Methotrexate—lymphatic system cancer	0.000475	0.00127	CcSEcCtD
Prednisone—Discomfort—Mitoxantrone—lymphatic system cancer	0.000473	0.00126	CcSEcCtD
Prednisone—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000471	0.00126	CcSEcCtD
Prednisone—Oedema—Vincristine—lymphatic system cancer	0.000471	0.00126	CcSEcCtD
Prednisone—Anorexia—Carmustine—lymphatic system cancer	0.000471	0.00126	CcSEcCtD
Prednisone—Infection—Vincristine—lymphatic system cancer	0.000468	0.00125	CcSEcCtD
Prednisone—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000466	0.00124	CcSEcCtD
Prednisone—Osteoarthritis—Methotrexate—lymphatic system cancer	0.000465	0.00124	CcSEcCtD
Prednisone—Nervous system disorder—Vincristine—lymphatic system cancer	0.000462	0.00123	CcSEcCtD
Prednisone—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000459	0.00123	CcSEcCtD
Prednisone—Oedema—Mitoxantrone—lymphatic system cancer	0.000459	0.00123	CcSEcCtD
Prednisone—Nausea—Fludarabine—lymphatic system cancer	0.000458	0.00122	CcSEcCtD
Prednisone—Infection—Mitoxantrone—lymphatic system cancer	0.000456	0.00122	CcSEcCtD
Prednisone—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000456	0.00122	CcSEcCtD
Prednisone—Shock—Mitoxantrone—lymphatic system cancer	0.000452	0.00121	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00045	0.0012	CcSEcCtD
Prednisone—Urticaria—Bleomycin—lymphatic system cancer	0.000449	0.0012	CcSEcCtD
Prednisone—Anorexia—Vincristine—lymphatic system cancer	0.000449	0.0012	CcSEcCtD
Prednisone—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000448	0.0012	CcSEcCtD
Prednisone—Body temperature increased—Bleomycin—lymphatic system cancer	0.000447	0.00119	CcSEcCtD
Prednisone—Insomnia—Carmustine—lymphatic system cancer	0.000447	0.00119	CcSEcCtD
Prednisone—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000446	0.00119	CcSEcCtD
Prednisone—Irritability—Methotrexate—lymphatic system cancer	0.000444	0.00119	CcSEcCtD
Prednisone—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000444	0.00119	CcSEcCtD
Prednisone—Paraesthesia—Carmustine—lymphatic system cancer	0.000443	0.00118	CcSEcCtD
Prednisone—Mood swings—Methotrexate—lymphatic system cancer	0.000441	0.00118	CcSEcCtD
Prednisone—Anorexia—Mitoxantrone—lymphatic system cancer	0.000438	0.00117	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000429	0.00115	CcSEcCtD
Prednisone—Decreased appetite—Carmustine—lymphatic system cancer	0.000429	0.00115	CcSEcCtD
Prednisone—Insomnia—Vincristine—lymphatic system cancer	0.000426	0.00114	CcSEcCtD
Prednisone—Paraesthesia—Vincristine—lymphatic system cancer	0.000423	0.00113	CcSEcCtD
Prednisone—Constipation—Carmustine—lymphatic system cancer	0.000422	0.00113	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000418	0.00112	CcSEcCtD
Prednisone—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000417	0.00111	CcSEcCtD
Prednisone—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000412	0.0011	CcSEcCtD
Prednisone—Decreased appetite—Vincristine—lymphatic system cancer	0.00041	0.00109	CcSEcCtD
Prednisone—Feeling abnormal—Carmustine—lymphatic system cancer	0.000407	0.00109	CcSEcCtD
Prednisone—Fatigue—Vincristine—lymphatic system cancer	0.000406	0.00109	CcSEcCtD
Prednisone—Asthenia—Bleomycin—lymphatic system cancer	0.000406	0.00108	CcSEcCtD
Prednisone—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000404	0.00108	CcSEcCtD
Prednisone—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000404	0.00108	CcSEcCtD
Prednisone—Constipation—Vincristine—lymphatic system cancer	0.000403	0.00108	CcSEcCtD
Prednisone—Pruritus—Bleomycin—lymphatic system cancer	0.0004	0.00107	CcSEcCtD
Prednisone—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000399	0.00107	CcSEcCtD
Prednisone—Fatigue—Mitoxantrone—lymphatic system cancer	0.000396	0.00106	CcSEcCtD
Prednisone—Pancreatitis—Methotrexate—lymphatic system cancer	0.000394	0.00105	CcSEcCtD
Prednisone—Constipation—Mitoxantrone—lymphatic system cancer	0.000393	0.00105	CcSEcCtD
Prednisone—Body temperature increased—Carmustine—lymphatic system cancer	0.00039	0.00104	CcSEcCtD
Prednisone—Abdominal pain—Carmustine—lymphatic system cancer	0.00039	0.00104	CcSEcCtD
Prednisone—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000385	0.00103	CcSEcCtD
Prednisone—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000378	0.00101	CcSEcCtD
Prednisone—Neutropenia—Methotrexate—lymphatic system cancer	0.000376	0.001	CcSEcCtD
Prednisone—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000375	0.001	CcSEcCtD
Prednisone—Abdominal pain—Vincristine—lymphatic system cancer	0.000373	0.000995	CcSEcCtD
Prednisone—Body temperature increased—Vincristine—lymphatic system cancer	0.000373	0.000995	CcSEcCtD
Prednisone—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.00037	0.000989	CcSEcCtD
Prednisone—Urticaria—Mitoxantrone—lymphatic system cancer	0.000365	0.000974	CcSEcCtD
Prednisone—Hypersensitivity—Carmustine—lymphatic system cancer	0.000364	0.000971	CcSEcCtD
Prednisone—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000363	0.000969	CcSEcCtD
Prednisone—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000363	0.000969	CcSEcCtD
Prednisone—Vomiting—Bleomycin—lymphatic system cancer	0.00036	0.00096	CcSEcCtD
Prednisone—Depression—Methotrexate—lymphatic system cancer	0.000358	0.000955	CcSEcCtD
Prednisone—Rash—Bleomycin—lymphatic system cancer	0.000357	0.000952	CcSEcCtD
Prednisone—Dermatitis—Bleomycin—lymphatic system cancer	0.000356	0.000952	CcSEcCtD
Prednisone—Asthenia—Carmustine—lymphatic system cancer	0.000354	0.000946	CcSEcCtD
Prednisone—Hypersensitivity—Vincristine—lymphatic system cancer	0.000347	0.000927	CcSEcCtD
Prednisone—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000338	0.000903	CcSEcCtD
Prednisone—Asthenia—Vincristine—lymphatic system cancer	0.000338	0.000903	CcSEcCtD
Prednisone—Diarrhoea—Carmustine—lymphatic system cancer	0.000338	0.000902	CcSEcCtD
Prednisone—Nausea—Bleomycin—lymphatic system cancer	0.000336	0.000897	CcSEcCtD
Prednisone—Asthenia—Mitoxantrone—lymphatic system cancer	0.000329	0.000879	CcSEcCtD
Prednisone—Dizziness—Carmustine—lymphatic system cancer	0.000327	0.000872	CcSEcCtD
Prednisone—Haemoglobin—Methotrexate—lymphatic system cancer	0.000324	0.000864	CcSEcCtD
Prednisone—Diarrhoea—Vincristine—lymphatic system cancer	0.000322	0.000861	CcSEcCtD
Prednisone—Haemorrhage—Methotrexate—lymphatic system cancer	0.000322	0.00086	CcSEcCtD
Prednisone—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000314	0.000839	CcSEcCtD
Prednisone—Vomiting—Carmustine—lymphatic system cancer	0.000314	0.000838	CcSEcCtD
Prednisone—Dizziness—Vincristine—lymphatic system cancer	0.000312	0.000832	CcSEcCtD
Prednisone—Rash—Carmustine—lymphatic system cancer	0.000311	0.000831	CcSEcCtD
Prednisone—Dermatitis—Carmustine—lymphatic system cancer	0.000311	0.000831	CcSEcCtD
Prednisone—Headache—Carmustine—lymphatic system cancer	0.000309	0.000826	CcSEcCtD
Prednisone—Eye disorder—Methotrexate—lymphatic system cancer	0.000301	0.000803	CcSEcCtD
Prednisone—Vomiting—Vincristine—lymphatic system cancer	0.0003	0.0008	CcSEcCtD
Prednisone—Rash—Vincristine—lymphatic system cancer	0.000297	0.000794	CcSEcCtD
Prednisone—Dermatitis—Vincristine—lymphatic system cancer	0.000297	0.000793	CcSEcCtD
Prednisone—Headache—Vincristine—lymphatic system cancer	0.000295	0.000789	CcSEcCtD
Prednisone—Nausea—Carmustine—lymphatic system cancer	0.000293	0.000783	CcSEcCtD
Prednisone—Angiopathy—Methotrexate—lymphatic system cancer	0.000292	0.00078	CcSEcCtD
Prednisone—Vomiting—Mitoxantrone—lymphatic system cancer	0.000292	0.000779	CcSEcCtD
Prednisone—Immune system disorder—Methotrexate—lymphatic system cancer	0.000291	0.000776	CcSEcCtD
Prednisone—Rash—Mitoxantrone—lymphatic system cancer	0.000289	0.000773	CcSEcCtD
Prednisone—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000289	0.000772	CcSEcCtD
Prednisone—Headache—Mitoxantrone—lymphatic system cancer	0.000288	0.000768	CcSEcCtD
Prednisone—Alopecia—Methotrexate—lymphatic system cancer	0.000284	0.00076	CcSEcCtD
Prednisone—Mental disorder—Methotrexate—lymphatic system cancer	0.000282	0.000753	CcSEcCtD
Prednisone—Malnutrition—Methotrexate—lymphatic system cancer	0.00028	0.000748	CcSEcCtD
Prednisone—Erythema—Methotrexate—lymphatic system cancer	0.00028	0.000748	CcSEcCtD
Prednisone—Nausea—Vincristine—lymphatic system cancer	0.00028	0.000748	CcSEcCtD
Prednisone—Nausea—Mitoxantrone—lymphatic system cancer	0.000273	0.000728	CcSEcCtD
Prednisone—Vision blurred—Methotrexate—lymphatic system cancer	0.000264	0.000705	CcSEcCtD
Prednisone—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00026	0.000694	CcSEcCtD
Prednisone—Anaemia—Methotrexate—lymphatic system cancer	0.000259	0.000692	CcSEcCtD
Prednisone—Malaise—Methotrexate—lymphatic system cancer	0.000253	0.000675	CcSEcCtD
Prednisone—Vertigo—Methotrexate—lymphatic system cancer	0.000252	0.000672	CcSEcCtD
Prednisone—Convulsion—Methotrexate—lymphatic system cancer	0.000243	0.000648	CcSEcCtD
Prednisone—Arthralgia—Methotrexate—lymphatic system cancer	0.000239	0.000637	CcSEcCtD
Prednisone—Myalgia—Methotrexate—lymphatic system cancer	0.000239	0.000637	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000237	0.000633	CcSEcCtD
Prednisone—Discomfort—Methotrexate—lymphatic system cancer	0.000236	0.000629	CcSEcCtD
Prednisone—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000229	0.000611	CcSEcCtD
Prednisone—Infection—Methotrexate—lymphatic system cancer	0.000227	0.000607	CcSEcCtD
Prednisone—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000224	0.000599	CcSEcCtD
Prednisone—Skin disorder—Methotrexate—lymphatic system cancer	0.000222	0.000593	CcSEcCtD
Prednisone—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000221	0.00059	CcSEcCtD
Prednisone—Anorexia—Methotrexate—lymphatic system cancer	0.000218	0.000582	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000208	0.000556	CcSEcCtD
Prednisone—Insomnia—Methotrexate—lymphatic system cancer	0.000207	0.000552	CcSEcCtD
Prednisone—Paraesthesia—Methotrexate—lymphatic system cancer	0.000205	0.000548	CcSEcCtD
Prednisone—Dyspepsia—Methotrexate—lymphatic system cancer	0.000201	0.000538	CcSEcCtD
Prednisone—Decreased appetite—Methotrexate—lymphatic system cancer	0.000199	0.000531	CcSEcCtD
Prednisone—Fatigue—Methotrexate—lymphatic system cancer	0.000197	0.000527	CcSEcCtD
Prednisone—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000188	0.000503	CcSEcCtD
Prednisone—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000187	0.000499	CcSEcCtD
Prednisone—Urticaria—Methotrexate—lymphatic system cancer	0.000182	0.000485	CcSEcCtD
Prednisone—Abdominal pain—Methotrexate—lymphatic system cancer	0.000181	0.000483	CcSEcCtD
Prednisone—Body temperature increased—Methotrexate—lymphatic system cancer	0.000181	0.000483	CcSEcCtD
Prednisone—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000168	0.00045	CcSEcCtD
Prednisone—Asthenia—Methotrexate—lymphatic system cancer	0.000164	0.000438	CcSEcCtD
Prednisone—Pruritus—Methotrexate—lymphatic system cancer	0.000162	0.000432	CcSEcCtD
Prednisone—Diarrhoea—Methotrexate—lymphatic system cancer	0.000156	0.000418	CcSEcCtD
Prednisone—Dizziness—Methotrexate—lymphatic system cancer	0.000151	0.000404	CcSEcCtD
Prednisone—Vomiting—Methotrexate—lymphatic system cancer	0.000145	0.000388	CcSEcCtD
Prednisone—Rash—Methotrexate—lymphatic system cancer	0.000144	0.000385	CcSEcCtD
Prednisone—Dermatitis—Methotrexate—lymphatic system cancer	0.000144	0.000385	CcSEcCtD
Prednisone—Headache—Methotrexate—lymphatic system cancer	0.000143	0.000383	CcSEcCtD
Prednisone—Nausea—Methotrexate—lymphatic system cancer	0.000136	0.000363	CcSEcCtD
